X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse JUBILANT LIFE SCIENCES with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 JUBILANT LIFE SCIENCES   ACTAVIS
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
ACTAVIS
Dec-14
JUBILANT LIFE SCIENCES/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs18718,752-   
Low Rs6511,438-   
Sales per share (Unadj.) Rs364.33,376.8-  
Earnings per share (Unadj.) Rs6.8-421.4-  
Cash flow per share (Unadj.) Rs24.5309.8-  
Dividends per share (Unadj.) Rs3.000-  
Dividend yield (eoy) %2.40-  
Book value per share (Unadj.) Rs164.97,324.1-  
Shares outstanding (eoy) m159.28265.90-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.34.5 7.7%   
Avg P/E ratio x18.4-35.8 -51.4%  
P/CF ratio (eoy) x5.148.7 10.6%  
Price / Book Value ratio x0.82.1 37.1%  
Dividend payout %43.80-   
Avg Mkt Cap Rs m20,0614,013,841 0.5%   
No. of employees `0006.221.6 28.6%   
Total wages/salary Rs m11,0520-   
Avg. sales/employee Rs Th9,383.041,568.6 22.6%   
Avg. wages/employee Rs Th1,786.90-   
Avg. net profit/employee Rs Th176.3-5,187.3 -3.4%   
INCOME DATA
Net Sales Rs m58,034897,882 6.5%  
Other income Rs m191-2,241 -8.5%   
Total revenues Rs m58,224895,641 6.5%   
Gross profit Rs m5,786115,346 5.0%  
Depreciation Rs m2,812194,424 1.4%   
Interest Rs m3,23728,321 11.4%   
Profit before tax Rs m-72-109,640 0.1%   
Minority Interest Rs m-2860-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2,145-8,043 -26.7%   
Tax Rs m696-5,637 -12.4%   
Profit after tax Rs m1,090-112,046 -1.0%  
Gross profit margin %10.012.8 77.6%  
Effective tax rate %-965.95.1 -18,787.6%   
Net profit margin %1.9-12.5 -15.1%  
BALANCE SHEET DATA
Current assets Rs m29,280473,069 6.2%   
Current liabilities Rs m38,912345,006 11.3%   
Net working cap to sales %-16.614.3 -116.4%  
Current ratio x0.81.4 54.9%  
Inventory Days Days8458 145.4%  
Debtors Days Days5166 76.5%  
Net fixed assets Rs m55,712109,640 50.8%   
Share capital Rs m1550-   
"Free" reserves Rs m20,9680-   
Net worth Rs m26,2651,947,473 1.3%   
Long term debt Rs m17,1691,020,514 1.7%   
Total assets Rs m88,6063,569,077 2.5%  
Interest coverage x1.0-2.9 -34.1%   
Debt to equity ratio x0.70.5 124.7%  
Sales to assets ratio x0.70.3 260.3%   
Return on assets %4.9-2.3 -208.2%  
Return on equity %4.2-5.8 -72.2%  
Return on capital %11.6-3.0 -384.2%  
Exports to sales %37.80-   
Imports to sales %16.50-   
Net fx Rs m10,2550-   
CASH FLOW
From Operations Rs m8,026154,184 5.2%  
From Investments Rs m-1,744-369,175 0.5%  
From Financial Activity Rs m-4,447207,423 -2.1%  
Net Cashflow Rs m1,834-7,568 -24.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 68.74 Rs / USD

Compare JUBILANT LIFE SCIENCES With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare JUBILANT LIFE SCIENCES With: CADILA HEALTHCARE  WYETH LTD  STERLING BIOTECH  ALEMBIC LTD  ELDER PHARMA  



Today's Market

Of IPOs, LIC-IDBI Bank Deal, and Top Cues in Focus Today(Pre-Open)

Share markets in India closed marginally higher on Friday last week. All sectoral indices traded in green, with stocks in the IT sector and stocks in the pharma sector, leading the gains.

Related Views On News

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY18); Net Profit Up 1.4% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 1.4% YoY). Sales on the other hand came in at Rs 23 bn (up 37.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

More Views on News

Most Popular

Sintex's Auditor Resigns. How You Can Protect Yourself from Such Stocks(The 5 Minute Wrapup)

Jul 20, 2018

While the attack on the bad corporate governance is an overhang in the near term...this can be a game-changer in the years to come.

The Answer to Your Wealth Worries: Small Caps (Especially Now)(Profit Hunter)

Jul 10, 2018

If you're worried about the markets - you are on the wrong track. This is opportunity - put your wealth-building hat on, instead - Richa shows you how...

The Multiple Problems with the Minimum Support Price (MSP) System(Vivek Kaul's Diary)

Jul 11, 2018

The price signals that MSP sends out, creates its own set of problems.

PPF v/s Mutual Funds: Which Is Better?(Outside View)

Jul 10, 2018

PersonalFN highlights the key points of distinction between PPF and mutual funds.

ICICI Pru Mutual Fund Tarakki Karega! - The Unethical Way?(Outside View)

Jul 11, 2018

PersonalFN explains how ICICI Prudential Mutual Fund flouted the norms of related party transactions while subscribing to the IPO of ICICI Securities.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Jul 20, 2018 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 5-YR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS